Consulta > Inglés > 2015
Promoting Medical Innovation and Access, Together
Global Challenges Brief
An overview of issues relevant to debates about solutions to global challenges, such as climate change, public health and food security.
Año de publicación: 2015
WIPO Magazine, Issue 5/2015 (October)
The WIPO Magazine explores intellectual property, creativity and innovation in action across the world.
Report of the Director General to the 2015 WIPO Assemblies
This report is a presentation of the work accomplished by the Organization during the year that has passed since the last meeting of the WIPO Assemblies.
Geneva Act of the Lisbon Agreement on Appellations of Origin and Geographical Indications
The Geneva Act allows the international registration of geographical indications (GIs), in addition to appellations of origin, and permits the accession to the Lisbon Agreement by certain intergovernmental organizations.
Global Innovation Index 2015
Effective Innovation Policies for Development
The Global Innovation Index ranks the innovation performance of 141 countries and economies around the world, based on 79 indicators. This edition explores the impact of innovation-oriented policies on economic growth and development. High-income and developing countries alike are seeking innovation-driven growth through different strategies. Some countries are successfully improving their innovation capacity, while others still struggle.
WIPO Re:Search: Sharing Innovation in the Fight Against Neglected Tropical Diseases
Private International Law Issues in Online Intellectual Property Infringement Disputes with Cross-Border Elements
An Analysis of National Approaches
The objective of this report is to contribute to the understanding of the issues at the interface between private international law and intellectual property through an empirical study, and to identify possible future activities in this area.
Guide to the International Patent Classification (2015)
Sources of Biopharmaceutical Innovation: An Assessment of Intellectual Property
Economic Research Working Paper No. 24
An analysis of new, FDA-approved molecular entities reveals dynamism in terms of new innovation. An assessment of the first patent for each drug reveals that the pharmaceutical industry, particularly large, established companies in North America, tend to dominate the field. Whereas inventors continue to found biotechnology companies at a steady rate, recent trends suggest these inventors more often come from the private sector.
WIPO Magazine, Issue 4/2015 (August)